Dupilumab Treatment for Prurigo Nodularis and Pruritis – References

Dupilumab Treatment for Prurigo Nodularis and Pruritis


  1. Legat F., et al. 2018. Pruritis and Dysesthesia. In: Bolognia J., Schaffer J.,Cerroni L., editors. Dermatology. 3rd ed. Elsevier. p. 111-127.
  2. Zeidler C., Tsianakas A. Pereira M., et al. Chronic prurigo of nodular type: a review. Acta Derm Venereol. 2018;98:173-79.
  3. Patel J., Dao H. Chronic Pruritis: A review of neurophysiology and associated immune neuromodulatory agents. Skin Therapy Lett. 2018;23(5):5-9.
  4. Oetjen L., Kim B. Interactions of the immune and sensory nervous systems in atopy. FEBS. 2018;285:3138-51.
  5. Tsianakas A., Luger T., Radin A. Dupilumab treatment improves quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a randomize, placebo-controlled clinical trial. BJD. 2018;178:408-14.
  6. Ruzicka T., Hanifin J., Furue M., et al. Anti-interleukin 31 receptor a antibody for atopic dermatitis. NEJM. 2017;376(9):826-35.
  7. Penzi R., Yasuda M., Manatis-Lornell A., et al. Hair Regrowth in a Patient with Alopecia Totalis and Atopic Dermatitis Treated with Dupilumab. JAMA Dermatol. 2018;154(11):1358-60.
  8. Kaye A., Gordon S., Devarapalli S., et al. Dupilumab for the treatment of recalcitrant bullous pemphigoid. JAMA Dermatol. 2018;154(10):1225-26.
  9. Gordon S., Robinson S., Abudu M., et al. Eosinophilic annular erythema treated with dupilumab. Pediatr Dermatol. 2018;35:e255-56.
  10. Weston G., Hooper J., Strober B. Dupilumab in the treatment of dyshidrosis: a report of two cases. J Drugs Dermatol. 2018;17(3):355-56.
  11. Beck K.M., Yang E.J., Sekhon S., et al. Dupilumab treatment for generalized prurigo nodularis. JAMA Dermatol. 2019;155(1):118-20.
  12. Mollanazar N.K., Elgash M., Weaver L., et al. Reduced itch associated with dupilumab treatment in 4 patients with prurigo nodularis. JAMA Dermatol. 2018 Nov 4.
  13. Calugareanu A., Jachiet M., Lepelletier C., et al. Dramatic improvement of generalized prurigo nodularis with dupilumab. J Eur Acad Dermatol Venereol. 2019;33(8):e303-04.